‘Breakthrough’ for vitamin K2
Another study with important implications for health was published in Osteoporosis International. The study, sponsored by NattoPharma, indicated that vitamin K2 supplements may reduce bone loss and improve bone impact strength in postmenopausal women.
Vladimir Badmaev, MD, PhD, Head of R&D for NattoPharma ASA told us: "The three-year study of MenaQ7 is a 'breakthrough' study because it shows for the first time clinically statistically significant protection of the vertebrae and the hip (femoral neck) against osteoporosis, cardiovascular deterioration and metabolic deterioration.
"While the 'breakthrough' studies may bring more awareness for vitamin K supplementation, even less awareness exists among manufacturers and end customers on the proper form and quality of vitamin K needed in supplements.
"NattoPharma has undertaken another 'breakthrough' project in the field of manufacture and technology of natural vitamin K. This led to the development of The MenaQ7 Crystals brand. What is probably the most significant technological breakthrough in the MenaQ7 Crystals manufacture is a proprietary multi-step process of purification, condensation and crystallization of fermentation-derived K2. MenaQ7Crystals fermentation-process starting materials and excipients are soy free and hypoallergenic," added Dr Badmaev.
